BioStem Technologies, Inc. (OTC: BSEM) Appoints New Members to Its Board of Directors
March 18 2016 - 2:46PM
Marketwired
BioStem Technologies, Inc. (OTC: BSEM) Appoints New Members to
Its Board of Directors
OAKLAND PARK, FL-(Marketwired - Mar 18, 2016) - BioStem
Technologies, Inc. (OTC PINK: BSEM) today announced it has
appointed Robert Watson, Henry VanVurst and Andrew VanVurst to its
Board of Directors. Watson is a veteran corporate executive and
strategist of the Biotech, Pharmaceutical and Financial sectors.
The appointment of these new board members was made effective March
17, 2016.
Since 1998, Robert Watson has been developing and executing
corporate strategy that increases the value of early stage
companies. He is best known for creating and executing scalable and
effective funding programs, but he has also developed and led
hundreds of complex strategic maneuvers that increased shareholder
value for his client companies, including capital structuring,
strategy development, strategic partnerships, mergers,
acquisitions, turnarounds, business model transitions, executive
recruitments, market repositioning's, sales strategy changes,
startups and spinoffs. He can quickly identify root causes of
mission critical corporate problems (including difficulties in
fundraising), and develop and execute the strategy necessary to
overcome those problems.
BioStem Technologies, Inc. is confident the acquisition of these
new members of the Board will allow for a rapid expansion into new
and developing sectors. With the expertise, background and
knowledge of these individuals from different sectors BioStem will
continue to grow and enhance its operations.
About BioStem Technologies, Inc. (OTC:BSEM): BioStem
Technologies (OTC: BSEM) is engaged in the advancement of
regenerative medicine and antiaging strategies throughout the
United States, Europe and Mexico. Our goal is to deliver the
highest standard wellness and stem cell products that are backed by
science. Through scientific studies, we seek to become a world
leader in the wellness arena. This will be accomplished by using
high quality nutraceuticals and stem cells. Our state-of-the-art
laboratory is the first significant step in our quest to introduce
the world and our shareholders to our dedication to you and your
well-being.
Mission Statement- BioStem Technologies, Inc. is a Global Leader
in Anti-Aging research. We are focused on advancing your quality of
life, health span and wellness.
Vision Statement- BioStem Technologies, Inc. is a group of
scientists, physicians, and visionaries creating the possibility of
living life to its fullest. Our products and strategies are
dedicated to helping you live your best, feel your best, and be
your best.
Forward-Looking Statements Except for statements of historical
fact, the matters discussed in this press release are forward
looking and made pursuant to the Safe Harbor provisions of the
Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or
strategies and are generally preceded by words such as "future,"
"plan" or "planned," "expects," believe" or "projected." These
forward-looking statements reflect numerous assumptions and involve
a variety of risks and uncertainties, many of which are beyond the
company's control that may cause actual results to differ
materially from stated expectations. These risk factors include,
among others, limited operating history, difficulty in developing,
exploiting and protecting proprietary technologies, intense
competition and additional risks factors as discussed in reports
filed by the company with OTC Markets.
Contact Information
Contact: BioStem Technologies, Inc. Phone: 954-380-8342 Website:
http://www.biostemtech.com Email: info@biostemtech.com Twitter:
@Biostemtech Facebook: Biostem Technologies
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From Apr 2024 to May 2024
BioStem Technologies (PK) (USOTC:BSEM)
Historical Stock Chart
From May 2023 to May 2024